Colorcon, a provider of development, supply and technical support of specialty products for the pharmaceutical industry, has established Colorcon Ventures to invest in promising companies in the pharmaceutical industry.
Cigna Ventures was created to help Cigna identify, assess and sponsor early-stage innovation ideas that warrant deeper exploration through focused pilot and test-and-learn activities with the goal of realizing meaningful business value.
In addition to increased funding, Pfizer will extend its leadership as a venture capital investor with an expanded team that leverages expertise across venture capital investing, business development, drug discovery and clinical development.